Bank of New York Mellon Corp - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$7,080,000
+139.2%
187,963
+8.0%
0.00%0.0%
Q4 2020$2,960,000
+417.5%
173,996
+43.1%
0.00%
Q3 2020$572,000
-24.0%
121,553
-1.6%
0.00%
Q2 2020$753,000
+136.8%
123,526
-11.9%
0.00%
Q1 2020$318,000
-46.5%
140,142
+8.3%
0.00%
Q4 2019$594,000
-2.9%
129,354
-18.1%
0.00%
Q3 2019$612,000
-36.7%
157,945
-1.5%
0.00%
Q2 2019$967,000
-57.8%
160,395
-6.2%
0.00%
-100.0%
Q1 2019$2,291,000
+43.8%
170,972
-0.1%
0.00%
Q4 2018$1,593,000
-33.5%
171,191
-0.6%
0.00%
-100.0%
Q3 2018$2,397,000
-5.4%
172,231
+7.5%
0.00%0.0%
Q2 2018$2,533,000
-12.6%
160,155
-5.1%
0.00%0.0%
Q1 2018$2,899,000
-12.0%
168,741
+12.3%
0.00%0.0%
Q4 2017$3,293,000
-64.3%
150,245
-33.3%
0.00%
-66.7%
Q3 2017$9,222,000
+34.1%
225,423
-1.3%
0.00%
+50.0%
Q2 2017$6,876,000
-15.0%
228,350
+2.0%
0.00%0.0%
Q1 2017$8,093,000
-28.1%
223,876
-0.3%
0.00%
-33.3%
Q4 2016$11,250,000
+48.4%
224,505
+55.4%
0.00%
+50.0%
Q3 2016$7,582,000
+23.0%
144,458
-3.1%
0.00%0.0%
Q2 2016$6,164,000
+15.5%
149,061
+13.5%
0.00%0.0%
Q1 2016$5,338,000
+5.5%
131,367
+7.7%
0.00%0.0%
Q4 2015$5,061,000
+194.1%
121,932
+9.0%
0.00%
+100.0%
Q3 2015$1,721,000
-44.5%
111,819
-10.5%
0.00%0.0%
Q2 2015$3,103,000
+56.0%
124,968
+43.6%
0.00%0.0%
Q1 2015$1,989,000
+15.1%
87,047
+36.0%
0.00%
Q4 2014$1,728,000
+117.1%
63,996
-5.7%
0.00%
Q3 2014$796,000
-63.3%
67,899
-51.2%
0.00%
Q2 2014$2,166,000
+473.0%
139,280
+624.9%
0.00%
Q1 2014$378,000
+97.9%
19,214
+68.7%
0.00%
Q4 2013$191,00011,3890.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 2,781,346$25,867,0003.38%
GREAT POINT PARTNERS LLC 2,398,409$22,305,0002.82%
Sofinnova Investments, Inc. 315,344$2,933,0000.36%
EcoR1 Capital, LLC 326,775$3,039,0000.30%
Rock Springs Capital Management LP 505,000$4,697,0000.22%
Hilltop Holdings Inc. 36,146$336,0000.08%
OXFORD ASSET MANAGEMENT LLP 285,237$2,653,0000.07%
PLATINUM INVESTMENT MANAGEMENT LTD 191,237$1,779,0000.06%
FOX RUN MANAGEMENT, L.L.C. 12,132$113,0000.06%
Virtus ETF Advisers LLC 31,427$292,0000.05%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders